HP
ONC

Havemeyer Place’s BeOne Medicines Ltd ONC Stock Holding History

Havemeyer Place’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$707K Sell
2,481
-1,990
-45% -$586K 0.07% 359
2026
Q1 		$1.33M Buy
4,471
+2,823
+171% +$914K 0.15% 252
2025
Q4 		$501K Buy
+1,648
New +$539K 0.1% 321

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Havemeyer Place's ONC Position: Q2 2026 in Review

Havemeyer Place reduced its BeOne Medicines Ltd (ONC) stake by 45% in Q2 2026, selling an estimated $586K and leaving 2,481 shares worth $707K. The position accounts for 0.07% of the portfolio, ranked #359.

Havemeyer Place first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.33M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Havemeyer Place held 2,481 shares of BeOne Medicines Ltd worth $707K as of Q2 2026.
  • Havemeyer Place sold 1,990 BeOne Medicines Ltd shares in Q2 2026, an estimated $586K.
  • BeOne Medicines Ltd made up 0.07% of Havemeyer Place's portfolio in Q2 2026, its #359 holding.
  • Havemeyer Place first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • Havemeyer Place's BeOne Medicines Ltd position peaked at $1.33M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.